| Stage | AA | % of rev | LBRDK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.7B | 100.00% | $246M | 100.00% | AA ×15.06 |
| Gross profit | $882M | 23.81% | $246M | 100.00% | LBRDK +76.2pp |
| Operating income | $583M | 15.74% | $21M | 8.54% | AA +7.2pp |
| Pre-tax income | $573M | 15.47% | $253M | 102.85% | LBRDK +87.4pp |
| Net income | $482M | 13.01% | $195M | 79.27% | LBRDK +66.3pp |
| Stage | AA | LBRDK | Gap · A − B |
|---|---|---|---|
| Revenue | $3.7B100.00% | $246M100.00% | AA ×15.06 |
| Gross profit | 23.81%$882M | 100.00%$246M | LBRDK +76.2pp |
| Operating income | 15.74%$583M | 8.54%$21M | AA +7.2pp |
| Pre-tax income | 15.47%$573M | 102.85%$253M | LBRDK +87.4pp |
| Net income |
| 13.01%$482M |
| 79.27%$195M |
| LBRDK +66.3pp |
No disclosed counterparties: LBRDK.
None